As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of Jade Biosciences, Inc. - COM (AVTE).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 0 | $0 | -$65,395 | $2.68 | 0 |
| 2025 Q2 | 24,414 | $65,395 | -$79,443,835 | $2.59 | 2 |
| 2025 Q1 | 31,698,351 | $79,562,623 | +$3,810,131 | $2.51 | 80 |
| 2024 Q4 | 30,167,836 | $79,943,765 | +$6,829,223 | $2.65 | 78 |
| 2024 Q3 | 27,643,944 | $57,772,365 | +$1,542,783 | $2.09 | 72 |
| 2024 Q2 | 27,181,632 | $45,121,583 | -$189,379,190 | $1.66 | 79 |
| 2024 Q1 | 28,456,703 | $841,465,274 | +$12,906,968 | $29.57 | 80 |
| 2023 Q4 | 28,185,162 | $637,829,902 | -$447,674 | $22.63 | 64 |
| 2023 Q3 | 28,465,427 | $386,275,633 | -$1,301,769 | $13.57 | 58 |
| 2023 Q2 | 28,473,066 | $488,311,378 | +$39,095,352 | $17.15 | 60 |
| 2023 Q1 | 25,984,813 | $524,111,604 | -$46,643,480 | $20.17 | 65 |
| 2022 Q4 | 27,403,700 | $802,925,527 | +$17,762,863 | $29.30 | 68 |
| 2022 Q3 | 26,982,564 | $447,365,690 | +$20,246,652 | $16.58 | 53 |
| 2022 Q2 | 25,769,304 | $402,774,000 | -$2,773,815 | $15.63 | 47 |
| 2022 Q1 | 25,927,935 | $475,262,000 | +$8,646,401 | $18.33 | 44 |
| 2021 Q4 | 25,569,932 | $301,454,000 | -$15,263,444 | $11.79 | 46 |
| 2021 Q3 | 21,654,813 | $452,572,000 | +$35,117,470 | $20.98 | 41 |
| 2021 Q2 | 19,965,251 | $454,425,000 | +$454,425,000 | $22.83 | 17 |